1887

Abstract

Thirty-five substituted benzimidazoles, benzotriazoles and quinoxalines were tested as growth inhibitors on three mutants of , strain W, having different purine requirements and on the ciliate . A number of the compounds, especially those with a nitro group in the benzene ring, were inhibitory. Both organisms were affected in a similar way by the compounds. Several of these analogues were tested for mutagenic activity at the purine and streptomycin loci in a purine-requiring mutant of . Only inhibitory compounds were found to be mutagenic; non-inhibitory concentrations of one analogue, 4-nitro-6-hydroxybenzimidazole (NHB), were, however, also mutagenic. No specific mutagenesis was demonstrated. NHB was found to increase the rate of mutation as determined by the papilla method. Evidence is presented which eliminates the hypothesis that selection rather than mutagenesis was involved. This analogue did not increase the frequency of mutants in non-dividing cells, and was not incorporated into bacterial DNA. The mechanism of this mutagenesis is thought to include the inhibition of enzymes concerned with DNA synthesis. DNA and RNA and their constituents, purine and pyrimidine precursors and analogues, vitamin B and other vitamins, were found to have no effect on the inhibition or mutagenesis produced by NHB. Several amino acid combinations and one non-mutagenic analogue, 4-hydroxy-6-nitrobenzotriazole, were, however, found to interfere with mutagenesis by NHB. These compounds did not affect the frequency of spontaneous mutants. The amino acid combination was effective only when present simultaneously with the mutagen and did not act by a selection mechanism. The mechanism of antimutagenesis by amino acids may involve their ability to increase the growth rate and also to modify the inhibited nucleic acid metabolism.

The mutagenesis by 5-nitroquinoxaline, a pterin analogue, was also found to be depressed by amino acids in the same purine-requiring mutant. The annulment of mutagenic activity by amino acids was strain and mutagen specific.

Twenty-five known inhibitors of nucleic acid synthesis and antagonists to inhibition were tested for mutagenic activity in five strains of . Several, including 6-mercaptopurine, were found to be mutagenic; in addition, NHB, 5-nitroquinoxaline and 5-aminouracil were mutagenic in most of the strains tested. The mutagenic activity of 5-aminouracil was not annulled by thymine, thymidine or other nucleic acid components, but the mutagenesis of 6-mercaptopurine was annulled by purine bases and by ribosides.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-18-3-543
1958-06-01
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/18/3/mic-18-3-543.html?itemId=/content/journal/micro/10.1099/00221287-18-3-543&mimeType=html&fmt=ahah

References

  1. Davis B.D. 1950; Studies on nutritionally deficient bacterial mutants isolated by means of penicillin. Experientia 6:41
    [Google Scholar]
  2. Duncan R.E., Woods P.S. 1953; Some cytological aspects of antagonism in synthesis of nucleic acid. Chromosoma 6:45
    [Google Scholar]
  3. Dunn D.B., Smith J.D. 1955; Occurrence of a new base in the desoxyribonucleic acid of a strain of Bacterium coli. . Nature; Lond.: 175336
    [Google Scholar]
  4. Elion G.B., Hitchings G.H., Vanderwerf H. 1951; Antagonists of nucleic acid derivatives. VI. Purines. J. biol. Chem 192:505
    [Google Scholar]
  5. Engelman M., Gillespie H.B., Greer S., Graff S. 1952; Inhibition by purine analogues. Proc. Amer. Ass. Cane. Res 1:1
    [Google Scholar]
  6. Fries N., Kihlman B. 1948; Fungal mutations obtained with methyl xanthines. Nature; Lond.: 162573
    [Google Scholar]
  7. Gillespie H.B., Engelman M., Graff S. 1954; Benzimidazoles and benzo- triazoles as growth antagonists. J. Amer. chem. Soc 76:3531
    [Google Scholar]
  8. Gillespie H.B., Engelman M., Graff S. 1956a; Some 4,5- and 5, 6-sub-stituted benzotriazoles. J. Amer. chem. Soc 78:1651
    [Google Scholar]
  9. Gillespie H.B., Engelman M., Graff S. 1956b; Some new benzimidazoles and quinoxalines. J. Amer. chem. Soc 78:2445
    [Google Scholar]
  10. Hirschberg E. 1955; Some contribution of microbiology to cancer research. Bact. Rev 19:65
    [Google Scholar]
  11. Kalckar H.M. 1954 Symposium on the Mechanism of Enzyme Action p. 692 Baltimore: The Johns Hopkins Press;
    [Google Scholar]
  12. Kidder G.W., Dewey V.C. 1949; The biological activity of substituted pyrimidines. J. biol. Chem 178:383
    [Google Scholar]
  13. Koch A.L. 1956; The metabolism of methyl purines by E. coli-, I. Tracer studies. J. biol. Chem 219:181
    [Google Scholar]
  14. Koch A.L., Lamont W.A. 1956; The metabolism of methyl purines hy E. coli-, II. Enzymatic studies. J. biol. Chem 219:189
    [Google Scholar]
  15. Kushner D.J., Pascal E. 1955; The action of benzimidazole on enzymatic adaptation. Canad. J. Biochem. Physiol 33:1
    [Google Scholar]
  16. Lee H.H. 1953; The mutation of E. coli resistance to bacteriophage T6 . Arch. Biochem. Biophys 47:438
    [Google Scholar]
  17. Liedke K.B., Engelman M., Graff S. 1954; The selective response of amphibian embryos to benzimidazole and benzotriazole derivatives. J. exp. Zool 127:201
    [Google Scholar]
  18. Liedke K.B., Engelman M., Graff S. 1955; Inhibitors of amphibian development. Anat. Rec 123:359
    [Google Scholar]
  19. Loveless L.E., Spoerl E., Weismann R.H. 1954; A survey of effects of chemicals on division and growth of yeast and E. coli. . J. Bact 68:637
    [Google Scholar]
  20. Mathews R.E.F., Smith J.D. 1956; Distribution of 8-azaguanine in the nucleic acids of Bacillus cereus. . Nature; Lond.: 177271
    [Google Scholar]
  21. Novick A. 1955; Mutagens and antimutagens, Brookkaven . Symp. in Biol 8:201
    [Google Scholar]
  22. Novick A., Szilard L. 1951; Experiments on spontaneous and chemically-induced mutations of bacteria growing in the chemostat. Cold. Spr. Harb. Symp. quant. Biol 16:337
    [Google Scholar]
  23. Novick A., Szilard L. 1952; Anti-mutagens. Nature; Lond.: 170926
    [Google Scholar]
  24. Pollock M.R. 1947; The adaptation of bacterial nitratase and tetrathionase in washed suspensions without growth and the relation of this adaptation to growth. Proc. Fourth int. Congr. Microbiol., Copenhagen p. 371
    [Google Scholar]
  25. Reichard P. 1955; Biosynthesis of purines and pyrimidines. In The Nucleic Adds Chargaff E., Davidson J. N. ed. II p. 277 New York: Academic Press Inc.;
    [Google Scholar]
  26. Roblin R.O. Jun. Lampen J.O., English J.P., Cole Q.P., Vaughan J.R. Jun. 1945; Methionine and purine antagonists and their relation to the sulfonamides. J. Amer. chem. Soc 67:290
    [Google Scholar]
  27. Ryan F.J. 1952; Adaptation to use lactose in E. coli. . J. gen. Microbiol 7:68
    [Google Scholar]
  28. Ryan F.J. 1953; Competitive suppression of prototrophs. Nature; Lond.: 171400
    [Google Scholar]
  29. Ryan F.J. 1954; The delayed appearance of mutants in bacterial cultures. Proc. nat. Acad. Sci., Wash 40:178
    [Google Scholar]
  30. Ryan F.J. 1955a; Phenotypic (phenomic) lag in bacteria. Amer. Nat 89:159
    [Google Scholar]
  31. Ryan F.J. 1955b; Spontaneous mutation in nondividing bacteria. Genetics 40:726
    [Google Scholar]
  32. Ryan F.J., Fried P., Schwartz M. 1954; Nuclear segregation and the growth of clones of bacterial mutants induced by ultraviolet light. J. gen. Microbiol 11:380
    [Google Scholar]
  33. Ryan F.J., Schneider L. 1948; The adaptive consequences of mutation during the growth of biochemical mutants of E. coli. . J. Bact 56:699
    [Google Scholar]
  34. Ryan F.J., Schwartz M., Fried P. 1955; The direct enumeration of spontaneous and induced mutations in bacteria. J. Bact 69:552
    [Google Scholar]
  35. Schlenk F. 1955; Biosynthesis of nucleosides and nucleotides. In The Nucleic Adds Chargaff E., Davidson J. N. ed. II p. 309 New York: Academic Press Inc;
    [Google Scholar]
  36. Scott D.B.M., Rogers M.L., Rose C., Chu E. 1957; Effect of the position and type of substituent in benzimidazole on inhibition of growth of microorganisms. Abstr. Pap. Amer. chem. Soc 131st Meeting p. 28 c:
    [Google Scholar]
  37. Smith J.D., Wyatt G.R. 1951; The composition of some microbial deoxy-pentose nucleic acids. Biochem. J 49:144
    [Google Scholar]
  38. Wainwright L.K. 1956; Spontaneous mutation in stored spores of Strepto- myces sp. J. gen. Microbiol 14:533
    [Google Scholar]
  39. Witkin E.M. 1950; The use of Na nucleate in the study of the mutagenic activity of acriflavin in E. coli. . Proc. nat. Acad. Sci., Wash 36:724
    [Google Scholar]
  40. Witkin E.M. 1956; Time, temperature, and protein synthesis: A study of ultraviolet-induced mutation in bacteria. Cold Spr. Harb. Symp. quant. Biol 21:123
    [Google Scholar]
  41. Woolley D.W. 1944; Some biological effects produced by benzimidazole and their reversal by purines. J. biol Chem 152:225
    [Google Scholar]
  42. Woolley D.W. 1951 A Study of Antimetabolites New York: John Wiley and Sons;
    [Google Scholar]
  43. Zamenhof S., Griboff G. 1954; E. coli containing 5 Br-uracil in its desoxy-ribosenucleic acid. Nature; Lond.: 174307
    [Google Scholar]
  44. Zamenhof S., Leidy G., Hahn E., Alexander H. 1956; Inactivation and unstabilization of the transforming principle by mutagenic agents. J.Bact 72:1
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-18-3-543
Loading
/content/journal/micro/10.1099/00221287-18-3-543
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error